Board

Fredrik Sjövall, Chairman

Born: 1980
Appointed: April 5, 2017.
Qualifications: M.Sc. Automation Engineering, Master’s Degree in Business Development. (Non-independent Board member according to Spotlight regulations.)
Experience: Fredrik was previously CEO of Inhalation Sciences, responsible for the company’s successful listing in 2017. Fredrik has been Chairman of Inhalation Sciences since May 2018. Previously he served as Chairman of Hemcheck AB, listed on Nasdaq First North. Fredrik has also been CEO of PharmaSurgics AB and Lipopeptide AB (now merged with Promore pharma AB).
Current roles: Chairman of the Board of Inhalation Sciences, Board member of Axelero AB and Lipidor AB.

Kristian Kierkegaard

Born: 1982
Appointed: May 18, 2018.
Qualifications: MBA with a Master’s Degree in Finance. (Independent Board member according to Spotlight regulations.)
Experience: Kristian has been an equity analyst at Remium Fondkommission and has been running his own investment company, Kristian Kierkegaard Holding AB, since 2011.
Current roles: Chairman of Kristian Kierkegaard Holding AB, Board member of AGOF Investments AB.

Ola Camber

Born: 1957
Appointed: 25 April 2018.
Qualifications: Qualified Pharmacist and Associate Professor in Pharmaceutical Sciences and Biopharmaceutics. (Independent Board member according to Spotlight regulations.)
Experience: Ola Camber has extensive experience in the pharmaceutical industry, including senior positions in formulation and drug delivery with, amongst others, Astra Zeneca. Ola is CEO of Camber Consulting AB, ClinStorage AB and ClinProducts AB.
Current roles: Board member of Camber Consulting AB, ClinStorage AB and ClinProducts AB

Mattias Münnich

Born: 1979
Appointed: 25 April 2018.
Qualifications: Bachelors in Financial Business Management, and Master’s Degree in Business Development from Chalmers School of Entrepreneurship. (Independent Board member according to Spotlight regulations.)
Experience: Mattias has worked with Product and Business Development in a range of pharmaceutical and medtech companies. He has been Chairman of Stayble Therapeutics AB, CEO of Acucort AB (listed on the stock market) and founder and Business Development manager at PharmaSurgics in Sweden AB (now ProMore Pharma AB, listed on First North).
Current roles: Currently he splits his time between VP Business Development Manager at Stayble Therapeutics AB and Life Science Business Coach at Chalmers Ventures AB.